The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity

Experimental Cell Research

Volumn 245, Issue 1, 1998, Pages 8-18

  Alessi, Francesca ^b   Quarta, Santina ^a   Savio, Monica ^a   Riva, Federica ^b   Rossi, Laura ^b   Stivala, Lucia A ^a   Scovassi, A Ivana ^b   Meijer, Laurent ^c   Prosperi, Ennio ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b CNR   (Italy)

^c STATION BIOLOGIQUE   (France)

Author keywords

Cyclin dependent kinases; Cyclins; Olomoucine; Rb protein; Roscovitine; Staurosporine

Indexed keywords

CELL DNA; CYCLIN DEPENDENT KINASE INHIBITOR; OLOMOUCINE; ROSCOVITINE; STAUROSPORINE;

ARTICLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; CYTOMETRY; DNA DETERMINATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL;

EID: 0031742097     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4216     Document Type: Article

References (53)

1. Nasmyth, K. (1993). Control of the yeast cell cycle by the cdc28 protein kinase. Curr. Opin. Cell Biol. 5, 166-179.
2. Pines, J. (1993). Cyclins and cyclin-dependent kinases: Take your partners. Trends Biochem. Sci. 18, 195-197.
3. Pines, J. (1995). Cyclins and cyclin-dependent kinases: A biochemical view. Biochem. J. 308, 697-711.
4. Morgan, D. O. (1995). Principle of cdk regulation. Nature 374, 131-134.
5. Sherr, C. J. (1996). Cancer cell cycles. Science 274, 1672-1677.
6. Nigg, E. A. (1995). Cyclin-dependent protein kinases: Key regulators of the eukaryotic cell cycle. Bioessays 17, 471-480.
7. Vesely, J., Havlicek, L., Strnad, M., Blow, J. J., Donella-Deana, A., Pinna, L., Letham, D. S., Kato, J., Detivaud, L., Leclerc, S., and Meijer, L. (1994). Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224, 771-786.
8. Schulze-Gahmen, U., Brandsen, J., Jones, H. D., Morgan, D. O., Meijer, L., Vesely, J., and Kim, S.-H. (1995). Multiple modes of ligand recognition: Crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine. Proteins Strut. Funct. Genet. 22, 378-391.
9. Glab, N., Labidi, H., Qin, L.-X., Trehin, C., Bergounioux, C., and Meijer, L. (1994). Olomoucine, an inhibitor of the cdc2/cdk2 kinases, blocks plant cells at the G1 to S and G2 to M cell cycle transitions. FEBS Lett. 353, 207-214.
10. Abraham, R. T., Acquarone, M., Andersen, A., Asensi, A., Bellè, R., Berger, F., Bergounioux, C., Brunn, G., Buquet-Fagot, C., Fagot, D., Glab, N., Goudeau, H., Guerrier, P., Houghton, P., Hendriks, H., Kloareg, B., Lippai, M., Marie, D., Maro, B., Meijer, L., Mester, J., Mulner-Lorillon, O., Poulet, S. A., Schierenberg, E., Schutte, B., Vaulot, D., and Verlhac, M. H. (1995). Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Biol. Cell 83, 105-120.
11. Misteli, T., and Warren, G. (1996). Mitotic disassembly of the Golgi apparatus in vivo. J. Cell Sci. 108, 2715-2727.
12. Schutte, B., Nieland, L., van Engeland, M., Henfling, M. E. R., Meijer, L., and Ramaekers, F. C. S. (1997). The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics. Exp. Cell Res. 236, 4-15.
13. Meijer, L. (1995). Chemical inhibitors of cyclin-dependent kinases. In "Progress in Cell Cycle Research" (L. Meijer, S. Guidet, and H. Y. L. Tung, Eds.), Vol. 1, pp. 351-363, Plenum Press, New York.
14. Bravo, R., Frank, R., Blundell, P. A., and MacDonald-Bravo, H. (1987). Cyclin/PCNA is the auxiliary protein of DNA polymerase 8. Nature 326, 515-517.
15. Prelich, G., Tan, C.-K., Kostura, M., Mathews, M. B., So, A. G., Downey, K. M., and Stillman, B. (1987). Functional identity of proliferating cell nuclear antigen and a DNA polymerase δ auxiliary protein. Nature 326, 517-520.
16. Bravo, R., and MacDonald-Bravo, H. (1987). Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J. Cell Biol. 105, 1549-1554.
17. Landberg, G., and Roos, G. (1991). Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis. Cancer Res. 51, 4570-4574.
18. Prosperi, E., Scovassi, A. I., Stivala, L. A., and Bianchi, L. (1994). Proliferating cell nuclear antigen bound to DNA replication sites: phosphorylation and association with cyclin D1 and cyclin A. Exp. Cell Res. 215, 257-262.
19. Weinberg, R. A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
20. Planas-Silva, M. D., and Weinberg, R. A. (1997). The restriction point and control of cell proliferation. Curr. Opin. Cell Biol. 9, 768-772.
21. Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., and Kato, J.-Y. (1994). D-type cyclin dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14, 2066-2076.
22. Meyerson, M., and Harlow, E. (1994). Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14, 2077-2086.
23. Connell-Crowley, L., Harper, J. W., and Goodrich, D. W. (1997). Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8, 287-301.
24. Zarkowska, T., and Mittnacht, S. (1997). Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272, 12737-12746.
25. Baldin, V., Lukas, J., Marcote, M. J., Pagano, M., and Draetta, G. (1993). Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7, 812-821.
26. Sewing, A., Burger, C., Brusselbach, S., Schalk, C., Lucibello, F. C., and Muller, R. (1993). Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J. Cell Sci. 104, 545-554.
27. Lukas, J., Pagano, M., Staskova, Z., Draetta, G., and Bartek, J. (1994). Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene 9, 707-718.
28. Sherr, C. J. (1995). D-type cyclins. Trends Biochem. Sci. 20, 187-190.
29. Sherr, C. J. (1994). G1 phase progression: Cyclin on cue. Cell 79, 551-555.
30. Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., and Pagano, M. (1995). Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15, 2612-2624.
31. Resnitzky, D., and Reed, S. I. (1995). Differential roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell Biol. 15, 3463-3469.
32. Pines, J., and Hunter, T. (1991). Human cyclins A and B1 are differentially located in the cell and undergo cell-cycle dependent nuclear transport. J. Cell Biol. 115, 1-17.
33. Girard, L., Strausfeld, U., Fernandez, A., and Lamb, N. J. C. (1991). Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67, 1169-1179.
34. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., and Draetta, G. (1992). Cyclin A is required at two points in the human cell cycle. EMBO J. 11, 961-971.
35. Zindy, F., Lamas, E., Chenivesse, X., Sobczack, J., Wang, J., Fesquet, D., Henglein, B., and Brèchot, C. (1992). Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun. 182, 1144-1154.
36. Fotedar, A., Cannella, D., Fitzgerald, P., Rouselle, T., Gupta, S., Dorée, M., and Fotedar, R. (1996). Role for cyclin A-dependent kinase in DNA replication in human S phase cell extracts. J. Biol. Chem. 271, 31627-31637.
37. Meijer, L. (1996). Chemical inhibitors of cyclin-dependent kinases. Trends Cell Biol. 6, 393-397.
38. Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Delcros, J.-G., and Moulinoux, J.-P. (1997). Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of cyclin-dependent kinase cdc2, cdk2 and cdk5. Eur. J. Biochem. 243, 527-536.
39. Crissman, H. A., Gadbois, D. M., Tobey, R. A., and Bradbury, E. M. (1991). Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle. Proc. Natl. Acad. Sci. USA 88, 7580-7584.
40. Gadbois, D. M., Crissman, H. A., Tobey, R. A., and Bradbury, E. M. (1992). Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells. Proc. Natl. Acad. Sci. USA 89, 8626-8630.
41. Schnier, J. B., Gadbois, D. M., Nishi, K., and Bradbury, E. M. (1994). The kinase inhibitor staurosporine induces G1 arrest at two points: Effect on retinoblastoma protein phosphorylation and cyclin-dependent kinase 2 in normal and transformed cells. Cancer Res. 54, 5959-5963.
42. Prosperi, E., Stivala, L. A., Sala, E., Scovassi, A. I., and Bianchi, L. (1993). Proliferating cell nuclear antigen complex formation induced by ultraviolet irradiation in human quiescent fibroblasts as detected by immunostaining and flow cytometry. Exp. Cell Res. 205, 320-325.
43. Scovassi, A. I., Stivala, L. A., Rossi, L., Bianchi, L., and Prosperi, E. (1997). Nuclear association of cyclin D1 in human fibroblasts: tight binding to nuclear structures and modulation by protein kinase inhibitors. Exp. Cell Res. 237, 127-134.
44. Van den Heuvel, S., and Harlow, E. (1993). Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262, 2050-2054.
45. Kitagawa, M., Higashi, H., Takahashi, S. I., Okabe, T., Ogino, H., Taya, Y., Nishimura, S., and Okuyama, A. (1994). A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression. Oncogene 9, 2549-2557.
46. Ongkeko, W., Ferguson, D. J. P., Harris, A. L., and Norbury, C. (1995). Inactivation of Cdc2 increases the level of apoptosis induced DNA damage. J. Cell Sci. 108, 2897-2904.
47. Park, D. S., Farinelli, S. E., and Greene, L. A. (1996). Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. J. Biol. Chem. 271, 8161-8169.
48. Gadbois, D. M., Peterson, S., Bradbury, E. M., and Lehnert, B. E. (1995). CDK4/Cyclin D1/PCNA complexes during staurosporine-induced G1 arrest and GO arrest of human fibroblasts. Exp. Cell Res. 220, 220-225.
49. Prosperi, E., Stivala, L. A., Scovassi, A. I., and Bianchi, L. (1997). Cyclins: Relevance of subcellular localization in cell cycle control. Eur. J. Histochem. 41, 161-168.
50. Gong, J., Traganos, F., and Darzynkiewicz, Z. (1994). Staurosporine blocks cell progression through G1 between the cyclin D and cyclin E restriction points. Cancer Res. 54, 3136-3139.
51. Lin, Y., Chrest, F. J., and Gabrielson, E. W. (1992). Reversible G1 arrest of a human lung epithelial cell line by staurosporine. J. Cell Physiol. 152, 646-653.
52. cdc2-like kinases. Biochem. Biophys. Res. Commun. 184, 80-85.
53. Carlson, B. A., Duibay, M. M., Sausville, E. A., Brizuela, L., and Worland, P. J. (1996). Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK2) and CDK4 in human breast carcinoma cells. Cancer Res. 56, 2973-2978.